Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis

NCT07719530 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: The SHR-1139 injection
DRUG: placebo

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd